Is Target a Dividend King?
Popular retail giant Target Corporation (NYSE:TGT) has been in a…
Buy
64
BBIO Quote, Financials, Valuation and Earnings
Last price:
$35.60
Seasonality move
:
4.17%
Day range:
$28.10 - $34.25
52-week range:
$21.62 - $41.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
28.24x
P/B ratio:
--
Volume:
10.1M
Avg. volume:
2M
1-year change:
-12.84%
Market cap:
$6.4B
Revenue:
$9.3M
EPS (TTM):
-$2.41
Earnings Data
Next earnings date for BBIO
Feb 21
2025
Most recent earnings per share
-$0.86
Missed by --
(Nov 12/2024)
Consensus Estimate
-$0.86
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BBIO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | $44M | -- | -- | -$0.68 | -- |
| 02/21/2025 | Q4 | $4M | -- | -- | -$1.09 | -- |
| 11/12/2024 | Q3 | $3.4M | $2.7M | -$0.86 | -$0.86 | -- |
| 08/01/2024 | Q2 | $4.5M | $2.2M | -$0.39 | -$0.94 | $0.55 |
| 05/02/2024 | Q1 | $83.8M | $211.1M | -$0.20 | -$0.54 | $0.34 |
| 02/22/2024 | Q4 | $3.8M | $1.7M | -$0.96 | -$0.80 | -$0.16 |
| 11/02/2023 | Q3 | -- | -- | -$1.08 | -$0.89 | -$0.19 |
| 08/03/2023 | Q2 | -- | -- | -$0.98 | -$0.88 | -$0.11 |
| 05/04/2023 | Q1 | -- | -- | -$0.92 | -$0.83 | -$0.09 |
| 02/23/2023 | Q4 | -- | -- | -$0.92 | -$0.94 | $0.02 |
| 11/03/2022 | Q3 | -- | -- | -$0.93 | -$1.01 | $0.08 |
| 08/04/2022 | Q2 | -- | -- | -$0.07 | -$0.86 | $0.79 |
| 05/05/2022 | Q1 | -- | -- | -$1.35 | -$1.10 | -$0.25 |
| 02/24/2022 | Q4 | -- | -- | -$1.01 | -$0.91 | -$0.10 |
| 11/04/2021 | Q3 | -- | -- | -$1.06 | -$0.91 | -$0.15 |
| 08/05/2021 | Q2 | -- | -- | -$0.66 | -$0.89 | $0.23 |
| 05/06/2021 | Q1 | -- | -- | -$1.18 | -$0.75 | -$0.43 |
| 02/25/2021 | Q4 | -- | -- | -$1.01 | -$0.86 | -$0.15 |
| 11/05/2020 | Q3 | -- | -- | -$0.98 | -$0.89 | -$0.09 |
| 08/11/2020 | Q2 | -- | -- | -$1.03 | -$0.73 | -$0.30 |
| 05/13/2020 | Q1 | -- | -- | -$0.78 | -$0.70 | -$0.08 |
| 03/02/2020 | Q4 | -- | -- | -$0.62 | -$0.63 | $0.01 |
| 11/07/2019 | Q3 | -- | -- | -$0.51 | -$0.54 | $0.03 |
| 08/14/2019 | Q2 | -- | -- | -$0.71 | -$0.40 | -$0.31 |
| 03/31/2019 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.42 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.34 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.33 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.40 | -- | -- |
BridgeBio Pharma Earnings Questions
-
How Much did BridgeBio Pharma Generate in Revenue Last Quarter?
BridgeBio Pharma reported $2.7M worth of top line sales in its most recent quarter.
-
Did BridgeBio Pharma Beat Earnings Last Quarter?
BridgeBio Pharma announced earnings per share of -$0.86 which represents a miss of analyst forecast a -$0.86 per share.
-
Is BridgeBio Pharma Profitable?
BridgeBio Pharma reported $2.1M that represents $0.01 per share over the last quarter.
-
What is the Analyst Consensus for BridgeBio Pharma EPS Next Year?
BridgeBio Pharma's earnings are forecast to decrease from -$3.95 per share to -$2.39 per share next year representing a decrease of -36.96%.
-
When is BridgeBio Pharma's Earnings Date?
BridgeBio Pharma's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is COWZ ETF a Good Investment?
There’s a reason even Warren Buffett advocates his heirs to…
3 Stocks Buffett Is Betting On
Warren Buffett appeared to take a hard look at the…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 39x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
40
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
61
ITCI alert for Jan 14
Intra-Cellular Therapies [ITCI] is down 0.26% over the past day.
Sell
30
ESTA alert for Jan 14
Establishment Labs Holdings [ESTA] is down 1.51% over the past day.
Buy
72
DJT alert for Jan 14
Trump Media & Technology Group [DJT] is down 8.25% over the past day.
